The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder
Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL
Medicine (Baltimore) · 2002
Grade Bnarrative review
Key Findings
- ●Comprehensive review of TRAPS clinical features and genetics
- ●Cysteine substitutions: higher penetrance (93% vs 82%) and amyloidosis risk (24% vs 2%)
- ●Preliminary evidence for etanercept efficacy
Referenced in (1 disease)
ID: pmid-12352631DOI: 10.1097/00005792-200209000-00002PMID: 12352631